4
Changes in Ownership
Cue Biopharma, Inc. Filed Acc 0000899243-21-045070
Director sold 20,176 shares at an average $17.93 ($361,690)
- Director acquired 20,176 shares (option exercise)
From the SEC's structured data for this filing
Trades in this filing
Kiener Peter A · Director
Table I: Non-derivative
4 lines| Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|
| 2021-11-15 | Exercise or conversion : show line 1 in the form | +18,815 | $2.86 | $53,811 | 18,815 | D |
| 2021-11-15 | Sale : show line 2 in the form | −18,815 | $17.92 | $337,165 | 0 | D |
| 2021-11-16 | Exercise or conversion : show line 3 in the form | +1,361 | $2.86 | $3,892 | 1,361 | D |
| 2021-11-16 | Sale : show line 4 in the form | −1,361 | $18.02 | $24,525 | 0 | D |
| Open-market sales · 20,176 sh · avg $17.93 · $361,690 | ||||||
Table II: Derivative
2 lines| Date | Transaction | Shares | Owned after | D/I |
|---|---|---|---|---|
| 2021-11-15 | Exercise or conversion : show line 5 in the form Stock Option (right to buy) | −18,815 | 107,105 | D |
| 2021-11-16 | Exercise or conversion : show line 6 in the form Stock Option (right to buy) | −1,361 | 105,744 | D |
Loading xslF345X03/doc4.xml…